Shopping Cart
- Remove All
- Your shopping cart is currently empty
EPI-7170 is a ralaniten analogue and a potent antagonist of the androgen receptor N-terminal structural domain, blocking the transcriptional activity of the full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 exhibits antitumor activity against enzalutamide resistant debulking resistant prostate cancer (CRPC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $931 | 8-10 weeks | |
50 mg | $1,210 | 8-10 weeks | |
100 mg | $1,940 | 8-10 weeks |
Description | EPI-7170 is a ralaniten analogue and a potent antagonist of the androgen receptor N-terminal structural domain, blocking the transcriptional activity of the full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 exhibits antitumor activity against enzalutamide resistant debulking resistant prostate cancer (CRPC). |
Molecular Weight | 540.88 |
Formula | C22H28Cl3NO6S |
Cas No. | 2139288-26-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.